Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 932 publications

Real-world observations on neuroinflammation-related drug responses in Alzheimer's disease.

Real-world observations on neuroinflammation-related drug responses in Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD
Published: September 12, 2025

Diagnosis and Treatment of Augmentation Syndrome Secondary to Ropinirole: A Case Report.

Diagnosis and Treatment of Augmentation Syndrome Secondary to Ropinirole: A Case Report.

Journal: Cureus
Published: August 29, 2025

Onapgo - an apomorphine subcutaneous infusion for Parkinson's disease.

Onapgo - an apomorphine subcutaneous infusion for Parkinson's disease.

Journal: The Medical letter on drugs and therapeutics
Published: July 12, 2025

Advanced P407/Tw80/βCD based Nasal Powders of Ropinirole Hydrochloride for Nose-to-Brain Delivery in Parkinson's Disease: Preparation and Comprehensive In Vitro and Ex Vivo Evaluation.

Advanced P407/Tw80/βCD based Nasal Powders of Ropinirole Hydrochloride for Nose-to-Brain Delivery in Parkinson's Disease: Preparation and Comprehensive In Vitro and Ex Vivo Evaluation.

Journal: The AAPS journal
Published: May 12, 2025

Cross-matrix multi-omics profiling identifies host-microbe interactions and diagnostic signatures in bovine subclinical mastitis.

Cross-matrix multi-omics profiling identifies host-microbe interactions and diagnostic signatures in bovine subclinical mastitis.

Journal: Frontiers in microbiology
Published: May 02, 2025

Neurostimulant Use for Rehabilitation and Recovery After Stroke: A Narrative Literature Review.

Neurostimulant Use for Rehabilitation and Recovery After Stroke: A Narrative Literature Review.

Journal: Stroke
Published: April 18, 2025

Othello Syndrome Induced by Dopamine Agonists in Parkinson's Disease: A Case Report.

Othello Syndrome Induced by Dopamine Agonists in Parkinson's Disease: A Case Report.

Journal: Case reports in psychiatry
Published: March 11, 2025

Optimized Design and Development of Ropinirole Loaded Nanoparticles for Restless Leg Syndrome.

Optimized Design and Development of Ropinirole Loaded Nanoparticles for Restless Leg Syndrome.

Journal: Journal of pharmacy & bioallied sciences
Published: January 31, 2025

Comparative safety signals of dopamine agonists: psychiatric and cardiovascular risks derived from FDA adverse event reporting system (FAERS) data.

Comparative safety signals of dopamine agonists: psychiatric and cardiovascular risks derived from FDA adverse event reporting system (FAERS) data.

Journal: BMC pharmacology & toxicology
Published: January 04, 2025

Ophthalmic ropinirole is an equally effective emetic agent in healthy dogs compared to intravenous apomorphine.

Ophthalmic ropinirole is an equally effective emetic agent in healthy dogs compared to intravenous apomorphine.

Journal: Frontiers in veterinary science
Published: January 01, 2025

Impulsive-compulsive behaviours and striatal neuroactivity in mildly parkinsonian rats under D2/3 agonist and L-DOPA treatment.

Impulsive-compulsive behaviours and striatal neuroactivity in mildly parkinsonian rats under D2/3 agonist and L-DOPA treatment.

Journal: NPJ Parkinson's disease
Published: December 20, 2024

Ropinirole Functions Through a Dopamine Receptor D2-Independent Mechanism to Ameliorate Amyotrophic Lateral Sclerosis Phenotypes in TARDBP-Mutant iPSC-Derived Motor Neurons.

Ropinirole Functions Through a Dopamine Receptor D2-Independent Mechanism to Ameliorate Amyotrophic Lateral Sclerosis Phenotypes in TARDBP-Mutant iPSC-Derived Motor Neurons.

Journal: Journal of neurochemistry
Published: December 19, 2024
Showing 1-12 of 932

Last Updated: 10/31/2025